NCT06369233View on ClinicalTrials.gov

Clinical Study to Evaluate the Anti-adhesion Efficacy and Safety of MegaShield®-SP in Comparison With Guardix-SP Plus After Spine Surgery

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Herniation, Disc
Interventions
DEVICE

MegaShield®-SP

MegaShield®-SP application Lumbar discectomy or laminectomy

DEVICE

Guardix-SP Plus

Guardix-SP Plus application Lumbar discectomy or laminectomy

Trial Locations (4)

13620

RECRUITING

Bundang Seoul National University Hospital, Seoul

03312

RECRUITING

Eunpyeong ST. Mary's Hospital, Seoul

03722

RECRUITING

Severance Hospital, Seoul

06273

RECRUITING

Gangnam Severance Hospital, Seoul

Sponsors

Lead Sponsor

L&C Bio
All Listed Sponsors
lead

L&C Bio

INDUSTRY